John
Park M.D., Ph.D., InvestigatorDr. Park received an Sc.B. from Brown University in 1985 and an M.D.,Ph.D. from Harvard Medical School in 1992. As an undergraduate,
he worked under Dr. Ford Ebner and characterized the growth of neocortical brain transplants. His graduate thesis under Drs.
Steven Burakoff and Fred Rosen was on the role of the CD43 molecule in the immune response. In 1998, he completed the Harvard
Medical School/Children's Hospital/Brigham and Women's Hospital neurosurgery residency program and joined the faculty of these
institutions. In the laboratory of Dr. Charles Stiles at the Dana-Farber Cancer Institute, he studied the role of immediate
early genes in neural stem cell development. He has received awards from the American Brain Tumor Association, the Pediatric
Section of the AANS and CNS, the New England Cancer Society, and the Neurosurgery Research and Education Foundation. Dr. Park
joined the NINDS as a tenure track investigator in 2002 and is head of the Surgical and Molecular Neuro-oncology Unit. His
laboratory investigates the mechanisms of brain tumor development and chemotherapy resistance. A board certified neurosurgeon,
Dr. Park specializes in the surgical treatment of patients with primary and metastatic brain tumors, particularly those in
eloquent brain areas.
Laboratory StaffYong Choi, Ph.D. Research Fellow
Tiffany Hodges, B.S. Clinical Fellow
301-451-
7207
Sariah Khormaee, B.S. Graduate Student
Andrea Sedlock, B.S., M.S Biologist
301-402-
6934
Research InterestsMalignant gliomas, the most common primary intrinsic tumors of the brain, are highly lethal and are associated with median
survivals of one to three years. In recent years, there has been increasing evidence that the cells of origin for these tumors
are transformed neural stem cells, commonly referred to as “tumor stem cells.” One focus of the laboratory is the characterization
of the normal and aberrant developmental processes used by these cells as they grow and develop into tumors. In particular,
we are examining the transcriptional events that drive the differentiation of normal and malignant neural stem cells into
astrocytes and glioma cells, respectively. The goal of the research is the identification and development of novel targets
and strategies for the treatment of malignant gliomas.
Selected Recent PublicationsLiang X-J, Choi Y, Sackett DL, Park JKNitrosoureas Inhibit the Stathmin-Mediated Migration and Invasion of Malignant Glioma Cells - Cancer Research
68 5267-72 2008
Jarboe JS, Johnson KR, Choi Y, Lonser RR, Park JKExpression of Interleukin-13 Receptor alpha 2 in Glioblastoma Multiforme: Implications for Targeted Therapies - Cancer Research
67 7983-7986 2007
Ngo TT, Peng T, Liang XJ, Akeju O, Pastorino S, Zhang W, Kotliarov Y, Zenklusen JC, Fine HA, Maric D, Wen PY, De Girolami
U, Black PM, Wu WW, Shen RF, Jeffries NO, Kang DW, Park JK.The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas. - J Natl Cancer Inst
99(8) 639-52 2007
Park DM, Li J, Okamoto H, Akeju O, Kim SH, Lubensky I, Vortmeyer A, Dambrosia J, Weil RJ, Oldfield EH, Park JK*, Zhuang P*
(*corresponding authors)N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation - Cell Cycle
6(4) 467-70 2007
Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, Pastorino S, Purow BW, Christopher N, Zhang W, Park JK, Fine HA.Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary
tumors than do serum-cultured cell lines. - Cancer Cell
9(5) 391-403 2006
Akeju O, Peng T, Park JK.Short hairpin RNA loop design for the facilitation of sequence verification. - Biotechniques
40(2) 154-156 2006
Selected Earlier Publications
Contact InformationSurgical Neurology Branch, NINDS Porter Neuroscience Research Center
Building 35, Room 2B-1002
35 Convent Drive, MSC 3706 Bethesda MD
20892-3706
Telephone:
301-402-
6935 (office), 301-
402-6935 (laboratory),
301-480-
0099 (fax), Email:
parkjo@ninds.nih.gov